KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, SH.Z. (2019) and chemokine receptors (CCL11, CX3CR1, CCR5, CCL5, CXCL12, CCL
2, and CCL17), adhesion molecules (PECAM1
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) for differentially expressed genes (DEGs) in ICH, with a fold change (FC) value of (|log
2FC|) >
2 and a P-value of <0
FENG, C.,
GONG, R.,
ZHENG, Q.Y.,
YANG, G.G.,
HE, M.Y.,
LEI, H.,
LI, X.D.,
ZHANG, L.,
XU, Z.H.,
LIU, S.Z.,
YU, M.X.,
MA, T.S.,
GAO, M.Q.,
BAMBA, D.,
IDIYATULLINA, E.T.,
ZAGIDULLIN, N.SH.,
PAVLOV, V.N.,
XU, C.Q.,
YUAN, Y.,
YANG, L. (2019) of proliferative cells, and increased apoptotic rate compared with any single treatments in U-
2 OS cells
CHEN, Q.,
HAN, B.,
MENG, X.,
DUAN, C.,
YANG, C.,
WU, Z.,
MAGAFUROV, D.,
ZHAO, S.,
JIANG, C.,
CAI, J.,
SAFIN, S (2019) remodels the GBM immunosuppressive microenvironment by down regulating M
2 macrophages and myeloid